The most common manifestation of pharmacokinetic interactions with warfarin involves the inhibition or induction of its metabolism. Attention should be paid to the relative importance of the ...

The Annals of Pharmacotherapy. 2008;42(6):790-805.

Steep costs have driven some Aussies to switch from brand-name medicine to its generic counterpart. Here's the price ...

Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to improve anticoagulation for patients with implanted cardiac ...

As compared with SAPT, warfarin alone was associated with a lower incidence of ischaemic stroke (HR ... Information on the dispension of oral antiplatelet and anticoagulant treatment was collected by ...

Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...

Vitamin K antagonists, such as warfarin, have an unpredictable pharmacokinetic profile and numerous food and drug interactions, which need frequent monitoring, creating a burden for patients and ...

But a generic version of this popular medication, sildenafil, is now widely available from several drug manufacturers at a fraction of the cost. Read on to find out more about this cheaper Viagra ...

Sept 24(Reuters) - The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator said on Tuesday, just days after the agency cleared ...

The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.